Healthcare of Ontario Pension Plan Trust Fund Grows Stock Holdings in Constellium SE $CSTM

Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of Constellium SE (NYSE:CSTM) by 894.4% in the first quarter, HoldingsChannel.com reports. The firm owned 2,056,336 shares of the industrial products company’s stock after acquiring an additional 1,849,554 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Constellium were worth $50,545,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CSTM. Royal Bank of Canada raised its stake in Constellium by 5.3% in the first quarter. Royal Bank of Canada now owns 72,526 shares of the industrial products company’s stock valued at $732,000 after buying an additional 3,629 shares in the last quarter. AQR Capital Management LLC lifted its holdings in Constellium by 354.0% during the 1st quarter. AQR Capital Management LLC now owns 91,566 shares of the industrial products company’s stock worth $924,000 after buying an additional 71,396 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Constellium by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 77,021 shares of the industrial products company’s stock worth $777,000 after acquiring an additional 3,393 shares in the last quarter. Prudential Financial Inc. acquired a new position in shares of Constellium during the 2nd quarter worth about $218,000. Finally, Norges Bank acquired a new position in shares of Constellium during the 2nd quarter worth about $1,499,000. Hedge funds and other institutional investors own 92.59% of the company’s stock.

Constellium Price Performance

Shares of NYSE CSTM opened at $29.02 on Friday. The company has a debt-to-equity ratio of 1.71, a current ratio of 1.39 and a quick ratio of 0.60. The stock has a fifty day moving average price of $32.11 and a 200 day moving average price of $28.23. Constellium SE has a 1-year low of $13.04 and a 1-year high of $36.99. The company has a market cap of $3.95 billion, a PE ratio of 9.39 and a beta of 1.55.

Constellium (NYSE:CSTM) last posted its quarterly earnings data on Wednesday, April 29th. The industrial products company reported $1.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.62 by $0.80. The firm had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.43 billion. Constellium had a net margin of 4.87% and a return on equity of 46.22%. Constellium’s quarterly revenue was up 24.4% on a year-over-year basis. During the same period last year, the firm posted $0.26 EPS. Sell-side analysts forecast that Constellium SE will post 3.41 EPS for the current year.

Insider Buying and Selling

In other news, Director Bradley Lee Soultz bought 2,500 shares of the stock in a transaction dated Thursday, May 14th. The shares were acquired at an average price of $33.84 per share, with a total value of $84,600.00. Following the completion of the acquisition, the director directly owned 2,500 shares in the company, valued at approximately $84,600. The trade was a ? increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Ludovic Piquier sold 1,000 shares of Constellium stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $33.57, for a total transaction of $33,570.00. Following the completion of the sale, the senior vice president directly owned 241,713 shares in the company, valued at approximately $8,114,305.41. The trade was a 0.41% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 195,153 shares of company stock worth $6,369,312. 1.20% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CSTM. UBS Group cut their target price on Constellium from $38.00 to $35.00 and set a “buy” rating on the stock in a research report on Wednesday, July 8th. Weiss Ratings downgraded Constellium from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, July 1st. BMO Capital Markets set a $32.00 price target on Constellium and gave the company an “outperform” rating in a report on Thursday, April 9th. Wells Fargo & Company dropped their price target on shares of Constellium from $39.00 to $37.00 and set an “overweight” rating on the stock in a research note on Thursday, July 9th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and set a $34.00 price objective (up from $30.00) on shares of Constellium in a report on Thursday, April 30th. Four equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $35.60.

Constellium Company Profile

Constellium SE is a global leader in the design and manufacture of high-performance aluminum products and solutions. The company serves key markets including aerospace, automotive, and packaging, offering advanced rolled and extruded aluminum sheet, plate and structural components. Its product portfolio encompasses precision-engineered parts for commercial and military aircraft, automotive body structures and closures, beverage and specialty packaging, as well as industrial and structural applications.

Established in 2011 through the consolidation of Rio Tinto Alcan’s rolled-products and engineered-products businesses, Constellium has built a reputation for innovation in lightweighting and sustainability.